For decades, the standard treatment for these potentially ... benralizumab could become the first new therapy approved for eosinophilic exacerbations of asthma and COPD in over 50 years.

A novel way of scanning lungs can demonstrate the impact of treatment on lung function in real-time, allowing experts to ...

THE first new treatment for asthma attacks in 50 years has been developed and could be "game-changing" for millions of people with the condition. Asthma attacks and chronic obstructive pulmonary ...

For decades, the standard treatment for these potentially ... benralizumab could become the first new therapy approved for eosinophilic exacerbations of asthma and COPD in over 50 years.

A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options ...

But it's appalling that this is the first new treatment for those suffering from asthma and COPD attacks in 50 years, indicating how desperately underfunded lung health research is. "Every four ...

Scientists say this is the first new way of treating the attacks in 50 years despite 3.8 million deaths across the world ...

New imaging techniques reveal real-time lung function improvements, offering a breakthrough in diagnosing and treating ...

More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more ...

For decades, the standard treatment for these potentially ... benralizumab could become the first new therapy approved for eosinophilic exacerbations of asthma and COPD in over 50 years.